Differences in the recognitionion of tumor-specific CD8+ T cell derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 978-981

  Kono, Koji ^a   Ichihara, Fumiko ^a   Iizuka, Hidehiko ^a   Sekikawa, Takayoshi ^a   Matsumoto, Yoshirou ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2; MITOMYCIN C; RECOMBINANT INTERLEUKIN 2; HLA ANTIGEN CLASS 1; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ASCITES; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; PRIORITY JOURNAL; STOMACH CANCER; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

AGED; AGED, 80 AND OVER; ASCITES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHATIC METASTASIS; MIDDLE AGED; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030610251     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<978::AID-IJC12>3.0.CO;2-2     Document Type: Article

References (20)

1. Cox, A.L., SKIPPER, J., CHEN, Y. HENDERSON, R.A., DARROWS, T.L., SHABANOWITZ, J., ENGELHARD, V.H., HUNT, D.F. and SLINCLUFF, C.L., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 264, 716-719 (1994).
2. FISK, B., BLEVINS, T.L., WHARTON, J.T. and IOANNIDES, C.G., Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte line. J. exp. Med., 181, 2109-2117 (1995).
3. IKEDA, H., SATO, N., MATSUURA, A. and KIKUTI, K., Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinoma. Cancer Res., 53, 3078-3084 (1993).
4. ITOH, K., PLATSOUCAS, C.D. and BALCH, C.M., Autologous tumor-specific cytotoxic T lympocytes in the infiltrate of human metastatic melanomas. Activation by interleukin-2 and autologeous tumor cells, and involvement of the T cell receptor. J. exp. Med., 168, 1419-1925 (1988).
5. KAWAKAMI, Y., ELIYAHU, S., SAKAGUTI, K., ROBBINS, P.F., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of the immunodominant peptide of the MART-1 human melanoma antigen recognized by the majority of HLA A2-restricted tumor infiltrating lymphocytes. J. exp. Med., 180, 347-352 (1994).
6. + T cell clones specific for the HER-2/neu proto-oncogene expressed on ovarian carcinomas: related and unrelated to decreased MHC class 1 expression. Int. J. Cancer (1997) in press.
7. LEHMANN, F., MARCHAND, M., HAINAUT, P., POUILLART, P., SASTRE, X., IKEDA, H., BOON, T. and COULIE, P.C., Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Europ. J. Immunol., 25, 340-347 (1995).
8. MAYORDOMO, J.I., ZORINA, T., STORKUS, W.J., ZITVOGEL, L., CELLUZZI, C., FALO, L.D., MELIEF, C.J., ILDSTAD, S.T., MARTINKAST, W., DELEO, A.B. and LOTZE, M.T., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature (Med.), 1, 1297-1302 (1995).
9. MIESCHER, S., STOECK, M., QIAO, L., BARRAS, C., BARRELET, L. and VON FLIEDNER, V., Preferential clonplogenic deficit of CDS-positive T-lymphocytes infiltrating human solid tumours. Cancer Res., 48, 6992-6998 (1988).
10. MISE, K., KAN, N., OKINO, T., MORIGUCHI, Y., HARADA, T., ICHINOSE, Y. and INOUE, K., OK-432-combined adoptive immunotherapy as a prognostic factor in peritoneal metastasis from gastric cancer. Jpn. J. Surg., 24, 54-58 (1994).
11. PEOPLE, G.E., GOEDEGEBUURE, P.S., ANDREWS, J.V.R., SCHOOF, D.D. and EBERLEIN, T.J., HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. J. Immunol., 151, 5481-5491 (1993a).
12. PEOPLE, G.E., SCHOOF, D.D., ANDREWS, J.V.R., GOEDECEBUURE, P.S. and EBERLEIN, T.J., T-cell recognition of ovarian cancer. Surgery. 114, 227-234 (1993b).
13. RATIO, G.B., ZINO, P., MIRABELLI, S., MINUTI, P., AQIUILINA, R., FRANTINO, G., SPESSA, E., PONTE, M., BRUZZI, P. and MELIOLI, G., A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected non-small cell lung carcinoma. Cancer, 78, 244-251 (1996).
14. RIVOLTINI, L., BARRACCHINI, K.C., VIGGIANO, V., KAWAKAMI, Y., SMITH, A., MIXON, A., RESTIFO, N.P., TOPALIAN, L., SIMONIS, T.B., ROSENBERG, S.A. and MARINCOLA, P.M., Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res., 55, 3149-3157 (1995).
15. ROSENBERG, S.A., PACKARD, B.S., AEBERSOLD, P.M., SOLOMON, D., TOPALIAN, S.L., TOY, S.T., SIMON, P., LOTZE, M.T., YANG, J.C., SEIPP, C.A., er al., Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N. Engl. J. Med., 319, 1676-1680 (1988).
16. SHIMIZU, Y., WEIDMANN, E., IWATSUKI, S., HERBERMAN, B. and WHITESIDE, T., Characterization of human autologous-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res., 51, 6153-6162 (1991).
17. STULLE, K., VOLLMERS, H.P., MARQUARDT, P. and MULLER-HERMELINK, H.K., Human stomach carcinoma-specific T cells derived from the tumor-draining lymph nodes. Brit. J. Cancer, 70, 1053-1059 (1994).
18. TRAVERSARI, C., VAN DER BRUGGEN, P., LEUSCHER, I.F., LURQUIN, C., CHOMEZ, P., VAN PEL, A., DE PLAEN, E., AMAR-COSTESEC, A. and BOON, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453-1457 (1992).
19. UYTTENHOVE, C., MARYANSKI, J. and BOON, T., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. exp. Med., 157, 1040-1052 (1983).
20. WHITESIDE, T.L., MIESCHER, S., MACDONALD, R.H. and VON FLIEDNER, V., Separation of tumor-infiltrating lymphocyte from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J. Immunol. Methods, 90, 221-233 (1986).